Table 3 Clinical and pathological characteristics of patients considering tumor recurrence
From: PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis
Tumor recurrence (N = 104) | No(87) | Yes(17) | p |
|---|---|---|---|
Characteristics | |||
Age (mean-yo) | 57.7 | 60.1 | 0.436 |
Gender | |||
Female | 21(24.1) | 3(17.6) | 0.561 |
Male | 66(75.9) | 14(82.4) | |
Tumor size (mean-cm) | 4.1 | 8.6 | <0.001 |
Presentation | |||
Incidental | 64(73.6) | 4(23.5) | <0.001 |
Symptomatic | 23(26.4) | 13(76.5) | |
Fuhrman nuclear grade | |||
1,2 | 57(65.5) | 8(47.1) | 0.150 |
3,4 | 30(34.5) | 9(52.9) | |
Nucleolar grade | |||
1 | 17(19.5) | 2(11.8) | 0.743 |
2 | 36(41.4) | 8(47.1) | |
3 | 24(39.1) | 7(41.2) | |
Microvascular invasion | |||
Absent | 70(80.5) | 5(29.4) | <0.001 |
Present | 17(19.5) | 12(70.6) | |
Tumor necrosis | |||
Absent | 72(82.8) | 9(52.9) | 0.007 |
Present | 15(17.2) | 8(47.1) | |
Tumor stage | |||
pT1 | 70(80.5) | 5(29.4) | <0.001 |
pT2,3 | 17(19.5) | 12(70.6) | |
Metastasis to lymph nodes | |||
Absent | 86(98.9) | 13(76.5) | <0.001 |
Present | 1(1.1) | 4(23.5) | |
PDL1 | |||
Negative | 39(44.8) | 6(35.3) | 0.468 |
Positive | 48(55.2) | 11(64.7) |